MXPA02005649A - Combinations of (s)-2 -(benzylamino -methyl)-2, 3, 8, 9, -tetrahydro-7h -1, 4-dioxino(2, 3)-e indol -8-one and neuroleptics. - Google Patents
Combinations of (s)-2 -(benzylamino -methyl)-2, 3, 8, 9, -tetrahydro-7h -1, 4-dioxino(2, 3)-e indol -8-one and neuroleptics.Info
- Publication number
- MXPA02005649A MXPA02005649A MXPA02005649A MXPA02005649A MXPA02005649A MX PA02005649 A MXPA02005649 A MX PA02005649A MX PA02005649 A MXPA02005649 A MX PA02005649A MX PA02005649 A MXPA02005649 A MX PA02005649A MX PA02005649 A MXPA02005649 A MX PA02005649A
- Authority
- MX
- Mexico
- Prior art keywords
- combinations
- dioxino
- neuroleptics
- benzylamino
- indol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Therapeutic combinations useful in the treatment or prevention of psychotic disorders, to pharmaceutical compositions containing said combinations, and to their use in the treatment or prophylaxis of prevention disorders are provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45860799A | 1999-12-10 | 1999-12-10 | |
PCT/US2000/033060 WO2001041750A2 (en) | 1999-12-10 | 2000-12-07 | Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02005649A true MXPA02005649A (en) | 2004-09-10 |
Family
ID=23821437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02005649A MXPA02005649A (en) | 1999-12-10 | 2000-12-07 | Combinations of (s)-2 -(benzylamino -methyl)-2, 3, 8, 9, -tetrahydro-7h -1, 4-dioxino(2, 3)-e indol -8-one and neuroleptics. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1235570A2 (en) |
JP (1) | JP5557409B2 (en) |
KR (1) | KR100772854B1 (en) |
CN (1) | CN1230164C (en) |
AR (1) | AR026756A1 (en) |
AU (1) | AU784211B2 (en) |
BR (1) | BR0016168A (en) |
CA (1) | CA2396351C (en) |
CZ (1) | CZ20021880A3 (en) |
EA (1) | EA005002B1 (en) |
HK (1) | HK1045942A1 (en) |
HU (1) | HUP0203309A3 (en) |
IL (2) | IL149669A0 (en) |
MX (1) | MXPA02005649A (en) |
NO (1) | NO20022739D0 (en) |
NZ (1) | NZ519381A (en) |
PL (1) | PL355292A1 (en) |
TW (1) | TWI222864B (en) |
WO (1) | WO2001041750A2 (en) |
ZA (1) | ZA200205484B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200517106A (en) | 2003-10-29 | 2005-06-01 | Wyeth Corp | Sustained release pharmaceutical compositions |
BRPI0608353A2 (en) | 2005-02-17 | 2009-12-01 | Wyeth Corp | indole, benzothiophene, benzofuran and indene cycloalkyl fused derivatives |
BRPI0907570A2 (en) * | 2008-02-13 | 2019-09-24 | Targacept Inc | alpha7 nicotinic agonists and antipsychotics |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2987484B2 (en) * | 1995-03-16 | 1999-12-06 | 大塚製薬 株式会社 | Method for producing carbostyril derivative |
US5756532A (en) | 1995-11-06 | 1998-05-26 | American Home Products Corporation | Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives |
GB9627005D0 (en) * | 1996-12-27 | 1997-02-12 | Knoll Ag | Therapeutic agents |
-
2000
- 2000-12-07 NZ NZ519381A patent/NZ519381A/en unknown
- 2000-12-07 PL PL00355292A patent/PL355292A1/en not_active Application Discontinuation
- 2000-12-07 AR ARP000106504A patent/AR026756A1/en unknown
- 2000-12-07 MX MXPA02005649A patent/MXPA02005649A/en active IP Right Grant
- 2000-12-07 JP JP2001543095A patent/JP5557409B2/en not_active Expired - Lifetime
- 2000-12-07 HU HU0203309A patent/HUP0203309A3/en unknown
- 2000-12-07 IL IL14966900A patent/IL149669A0/en active IP Right Grant
- 2000-12-07 EP EP00982461A patent/EP1235570A2/en not_active Withdrawn
- 2000-12-07 CZ CZ20021880A patent/CZ20021880A3/en unknown
- 2000-12-07 CA CA002396351A patent/CA2396351C/en not_active Expired - Lifetime
- 2000-12-07 KR KR1020027007286A patent/KR100772854B1/en not_active IP Right Cessation
- 2000-12-07 CN CNB008169527A patent/CN1230164C/en not_active Expired - Lifetime
- 2000-12-07 AU AU19490/01A patent/AU784211B2/en not_active Ceased
- 2000-12-07 BR BR0016168-3A patent/BR0016168A/en not_active Application Discontinuation
- 2000-12-07 WO PCT/US2000/033060 patent/WO2001041750A2/en active IP Right Grant
- 2000-12-07 EA EA200200656A patent/EA005002B1/en not_active IP Right Cessation
- 2000-12-08 TW TW089126071A patent/TWI222864B/en not_active IP Right Cessation
-
2002
- 2002-05-15 IL IL149669A patent/IL149669A/en not_active IP Right Cessation
- 2002-06-07 NO NO20022739A patent/NO20022739D0/en not_active Application Discontinuation
- 2002-07-09 ZA ZA200205484A patent/ZA200205484B/en unknown
- 2002-10-09 HK HK02107378.5A patent/HK1045942A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ519381A (en) | 2004-04-30 |
NO20022739L (en) | 2002-06-07 |
KR100772854B1 (en) | 2007-11-02 |
CN1230164C (en) | 2005-12-07 |
AU784211B2 (en) | 2006-02-23 |
CA2396351C (en) | 2009-11-10 |
KR20030016207A (en) | 2003-02-26 |
BR0016168A (en) | 2002-08-20 |
EP1235570A2 (en) | 2002-09-04 |
WO2001041750A3 (en) | 2002-02-14 |
CN1409633A (en) | 2003-04-09 |
PL355292A1 (en) | 2004-04-05 |
TWI222864B (en) | 2004-11-01 |
JP5557409B2 (en) | 2014-07-23 |
AU1949001A (en) | 2001-06-18 |
EA200200656A1 (en) | 2002-12-26 |
HUP0203309A3 (en) | 2004-12-28 |
HK1045942A1 (en) | 2002-12-20 |
HUP0203309A2 (en) | 2003-01-28 |
EA005002B1 (en) | 2004-10-28 |
AR026756A1 (en) | 2003-02-26 |
NO20022739D0 (en) | 2002-06-07 |
WO2001041750A2 (en) | 2001-06-14 |
JP2003516350A (en) | 2003-05-13 |
ZA200205484B (en) | 2003-12-31 |
IL149669A0 (en) | 2002-11-10 |
CZ20021880A3 (en) | 2002-08-14 |
CA2396351A1 (en) | 2001-06-14 |
IL149669A (en) | 2006-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267381A (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
TWI265808B (en) | Valdecoxib compositions | |
EP1259240B8 (en) | Agents, such as nicotinamide or cadpr for the treatment of skin disorders | |
AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
HUP0104795A3 (en) | Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use | |
FI956014A (en) | Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
MXPA02004701A (en) | Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders. | |
AU2300001A (en) | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease | |
IL140588A0 (en) | Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents | |
GR1003490B (en) | Novel pharmaceutical compositions comprising a salt of paraxetine | |
SE0001916D0 (en) | Novel formulation | |
PL355292A1 (en) | Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics | |
AP2000001946A0 (en) | Form V1 5,6-Dichloro-2-(isopropylamino)-1-(B-L-Ribofuranosyl)-1H- benzimidazole. | |
BG104914A (en) | Paroxetine maleate | |
JO2199B1 (en) | Substituted pyrroles | |
WO2004006887A3 (en) | Composition and methods for the treatment of skin disorders | |
TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
AU3992897A (en) | Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders | |
AU2002357691A1 (en) | Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 | |
TNSN00242A1 (en) | VALDECOXIB COMPOSITIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |